{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:48:51Z","timestamp":1770482931805,"version":"3.49.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T00:00:00Z","timestamp":1299628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017850","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T22:09:56Z","timestamp":1299708596000},"page":"e17850","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":155,"title":["Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer"],"prefix":"10.1371","volume":"6","author":[{"given":"Bin","family":"Bao","sequence":"first","affiliation":[]},{"given":"Shadan","family":"Ali","sequence":"additional","affiliation":[]},{"given":"Dejuan","family":"Kong","sequence":"additional","affiliation":[]},{"given":"Sanila H.","family":"Sarkar","sequence":"additional","affiliation":[]},{"given":"Zhiwei","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Sanjeev","family":"Banerjee","sequence":"additional","affiliation":[]},{"given":"Amro","family":"Aboukameel","sequence":"additional","affiliation":[]},{"given":"Subhash","family":"Padhye","sequence":"additional","affiliation":[]},{"given":"Philip A.","family":"Philip","sequence":"additional","affiliation":[]},{"given":"Fazlul H.","family":"Sarkar","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009.","volume":"59","author":"A Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"ref2","article-title":"Pancreatic cancer spheres are more than just aggregates of stem marker positive cells.","author":"M Gaviraghi","year":"2010","journal-title":"Biosci Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2010.03.004","article-title":"Cancer stem cells in solid tumors.","volume":"20","author":"PC Hermann","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00423-009-0502-z","article-title":"Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.","volume":"395","author":"I Ischenko","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1200\/JCO.2008.16.6702","article-title":"Pancreatic cancer stem cells.","volume":"26","author":"CJ Lee","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref6","first-page":"602","article-title":"Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis.","volume":"2","author":"MT Mueller","year":"2010","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/np0500171","article-title":"A labdane diterpene glucoside from the rhizomes of Curcuma mangga.","volume":"68","author":"F Abas","year":"2005","journal-title":"J Nat Prod"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials.","volume":"65","author":"H Hatcher","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/B:HIJO.0000032361.98815.bb","article-title":"Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways.","volume":"35","author":"S Narayan","year":"2004","journal-title":"J Mol Histol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1007\/s11095-009-9955-6","article-title":"Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice.","volume":"26","author":"S Padhye","year":"2009","journal-title":"Pharm Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1007\/s11095-009-9900-8","article-title":"New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells.","volume":"26","author":"S Padhye","year":"2009","journal-title":"Pharm Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1158\/0008-5472.CAN-09-4598","article-title":"Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.","volume":"70","author":"S Ali","year":"2010","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","article-title":"MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.","volume":"65","author":"JA Chan","year":"2005","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11605-008-0584-x","article-title":"MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival.","volume":"12","author":"M Dillhoff","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.","volume":"133","author":"F Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/sj.onc.1206390","article-title":"Role of NF-kappaB and Akt\/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.","volume":"22","author":"A Arlt","year":"2003","journal-title":"Oncogene"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-540-71279-4_17","article-title":"NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.","volume":"177","author":"S Sebens","year":"2008","journal-title":"Recent Results Cancer Res"},{"key":"ref18","first-page":"185","article-title":"NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).","volume":"29","author":"Z Zhang","year":"2006","journal-title":"Int J Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/bcr1021","article-title":"Mammary stem cells, self-renewal pathways, and carcinogenesis.","volume":"7","author":"S Liu","year":"2005","journal-title":"Breast Cancer Res"},{"key":"ref20","first-page":"489","article-title":"Pancreatic cancer stem cells and EMT in drug resistance and metastasis.","volume":"64","author":"FH Sarkar","year":"2009","journal-title":"Minerva Chir"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10911-010-9173-1","article-title":"Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.","volume":"15","author":"CJ Creighton","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11095-010-0105-y","article-title":"Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.","volume":"27","author":"Y Li","year":"2010","journal-title":"Pharm Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drup.2010.02.001","article-title":"Implication of microRNAs in drug resistance for designing novel cancer therapy.","volume":"13","author":"FH Sarkar","year":"2010","journal-title":"Drug Resist Updat"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","article-title":"miR-146a suppresses invasion of pancreatic cancer cells.","volume":"70","author":"Y Li","year":"2010","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/138920208784139555","article-title":"MicroRNA and Cancer: Tiny Molecules with Major Implications.","volume":"9","author":"TG Vandenboom Ii","year":"2008","journal-title":"Curr Genomics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR-21: a small multi-faceted RNA.","volume":"13","author":"AM Krichevsky","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.cgh.2009.07.042","article-title":"Chronic pancreatitis and pancreatic cancer: prediction and mechanism.","volume":"7","author":"T Shimosegawa","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc2842","article-title":"Phosphoinositide signalling in cancer: beyond PI3K and PTEN.","volume":"10","author":"TD Bunney","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/stem.101","article-title":"miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.","volume":"27","author":"D Kong","year":"2009","journal-title":"Stem Cells"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.","volume":"69","author":"Y Li","year":"2009","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11095-010-0106-x","article-title":"FoxM1 is a novel target of a natural agent in pancreatic cancer.","volume":"27","author":"Z Wang","year":"2010","journal-title":"Pharm Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1593\/tlo.09193","article-title":"Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.","volume":"2","author":"Y Yu","year":"2009","journal-title":"Transl Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1158\/1535-7163.1421.3.11","article-title":"Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.","volume":"3","author":"BF El-Rayes","year":"2004","journal-title":"Mol Cancer Ther"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0205300","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"record-id":"19276"},{"DOI":"10.1371\/journal.pone.0205300","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T17:40:24Z","timestamp":1685986824000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017850"}},"subtitle":[],"editor":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017850","relation":{"retraction":[{"id-type":"doi","id":"10.1371\/journal.pone.0205300","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,9]]}}}